Education
About Us
Working with TipRanks
Follow Us
Paul Matteis Profile - Stifel Nicolaus Analyst
312 Followers
Paul Matteis Stifel Nicolaus
Wall Street Analyst
Success Rate
230 out of 476 ratings made a profit
Average Return
+13.70%
Average return per rating
Time Frame
Compare to
Copying Paul Matteis's trades since 2016 and holding each position for 1 Year would result in 48.32% of your transactions generating a profit, with an average return of 13.7% per rating.
Stock Rating Distribution
69.53% Buy
30.47% Hold
0.00% Sell
Distribution of Paul Matteis's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Paul Matteis
Paul Matteis's Stock Coverage
Tempest Therapeutics
May 06, 2016
Hold
Reiterated
$7.00
(131.40% Upside)
2Ratings
―
0.00%
Calithera Bio
May 19, 2016
Buy
Reiterated
―
3Ratings
+64.15%
Ignyta Inc
May 19, 2016
Buy
Reiterated
―
3Ratings
+8.05%
OncoMed Pharma
Jun 05, 2016
Hold
Reiterated
―
4Ratings
―
0.00%
Orexigen
Jun 10, 2016
Hold
Reiterated
―
10Ratings
-76.40%
Fate Therapeutics
Jun 20, 2016
Buy
Reiterated
―
4Ratings
+71.25%
Theravance Biopharma
Jun 20, 2016
Buy
Reiterated
$29.00
(57.35% Upside)
5Ratings
+89.35%
Melinta Therapeutics
Jun 23, 2016
Hold
Assigned
―
4Ratings
―
0.00%
Sio Gene Therapies
Jun 29, 2016
Buy
Reiterated
―
2Ratings
+58.50%
AC Immune SA
Nov 23, 2016
Buy
Reiterated
―
1Ratings
-1.30%
List of latest recommendations made by Paul Matteis. Click to expand and see Paul Matteis's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Paul Matteis activity FAQ
What is the performance of Paul Matteis's recommendations?
The percentage of profitable recommendations made by Paul Matteis is 48%, and the average return per transaction is 13.70%.
What was Paul Matteis's most profitable rating?
Paul Matteis’s most profitable ratings was a buy on ANRO stock on Jun 30, 2025 - Today. The return on the trade was +543.10%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here